Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - carbidopa; levodopa - tablets - levodopa 250 mg; carbidopa 25 mg - levodopa - levodopa - for the relief of symptoms associated with parkinson's disease.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - carbidopa as monohydrate; levodopa - tablets controlled release - levodopa 200 mg; carbidopa as monohydrate 50 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - idiopathic parkinson's disease. postencephalitic parkinsonism. symptomatic parkinsonism. to reduce "off" time in patients previously treated with levodopa/decarboxylase inhibitor preparations, or with levodopa alone, who have had motor fluctuations characterized by end-of-dose deterioration ("wearing-off" phenomenon), peak dose dyskinesias, akinesia, or similar evidence of short-duration motor disturbances.

Israel - English - Ministry of Health

eldan electronic instruments co ltd - ioflupane - solution for injection - ioflupane 74 mbq/ml - iodine ioflupane (123i) - other dopaminergic agents - datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson's disease multiple system atrophy and progressive supranuclear palsy. - datscan is unable to discriminate between parkinson's disease multiple system atrophy and progressive supranuclear palsy. - in adult patients to help differentiate probable dementia with lewy bodies from alzheimer's disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson's disease dementia

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - carbidopa; levodopa - prolonged-release tablet - 25 mg/100 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - carbidopa; levodopa - tablet - 10 mg/100 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - levodopa; carbidopa - tablet - 25 mg/250 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - carbidopa; levodopa - tablet - 12.5 mg/50 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - levodopa; carbidopa - prolonged-release tablet - 50 mg/ 200 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - levodopa, carbidopa - tablet prolonged release - 50/200 milligram - dopa and dopa derivatives

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - levodopa; carbidopa - tablet - 25 mg/100 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor